AXGN logo

Axogen Inc. (AXGN)

$35.38

Quotes are delayed by 15 minutes.

1D

1W

1M

3M

6M

YTD

1Y

2Y

5Y

ALL

Key data on AXGN

Market cap

$1.77B

EPS

-0.05

P/E ratio

--

Price to sales

8.24

Dividend yield

--

Beta

0.994603

Price on AXGN

Previous close

$35.30

Today's open

$35.08

Day's range

$34.81 - $35.89

52 week range

$9.22 - $36.00

Profile about AXGN

CEO

Michael Dale

Employees

451

Headquarters

Alachua, FL

Exchange

NASDAQ Capital Market

Shares outstanding

50117283

Issue type

Common Stock

AXGN industries and sectors

Healthcare

Medical Equipment & Supplies

News on AXGN

HighMark Wealth Management Buys 158,855 Shares of Axogen Stock

HighMark Wealth Management LLC added 158,855 shares of Axogen. The quarter-end value of the stake rose by $7.9 million, reflecting both trading activity and share price movement.

news source

The Motley Fool • 13 hours ago

news preview

Axogen, Inc. (AXGN) Q4 2025 Earnings Call Transcript

Axogen, Inc. (AXGN) Q4 2025 Earnings Call Transcript

news source

Seeking Alpha • 10 hours ago

news preview

AxoGen (AXGN) Q4 Earnings Miss Estimates

AxoGen (AXGN) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.14 per share. This compares to earnings of $0.08 per share a year ago.

news source

Zacks Investment Research • 11 hours ago

news preview

First Eagle Small Cap Opportunity Fund Q4 2025 Portfolio Review

First Eagle Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of 1.71% in fourth quarter 2025. Small Cap Opportunity Fund A Shares (without sales charge*) posted a return of 1.71% in fourth quarter 2025.

news source

Seeking Alpha • Feb 19, 2026

news preview

Axogen, Inc. to Participate in Multiple Upcoming Investor Conferences

ALACHUA, Fla. and TAMPA, Fla., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that management is scheduled to participate in three upcoming investor conferences:

news source

GlobeNewsWire • Feb 17, 2026

news preview

Axogen, Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 24, 2026

ALACHUA, Fla. and TAMPA, Fla., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Axogen, Inc. (Nasdaq: AXGN), a global leader in developing and marketing innovative surgical solutions for the restoration of peripheral nerve function, today announced that it will release financial results for the fourth quarter and full year 2025 on Tuesday, February 24, 2026. Axogen management will host an investment-community conference call and webcast at 8:00 a.m. ET following the release.

news source

GlobeNewsWire • Feb 10, 2026

news preview

Wasatch Micro Cap Fund Q4 2025 Performance Review

Leading individual contributors to the Fund's relative performance included Axogen, Inc., a holding within the health-care equipment industry. A provider of prepared food items such as meatballs and paninis, Mama's targets the deli area of grocery stores and warehouse clubs. On the downside, software distribution company Climb Global Solutions, Inc. was the Fund's leading laggard in the quarter.

news source

Seeking Alpha • Feb 4, 2026

news preview

Axogen Announces Proposed Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

news source

GlobeNewsWire • Jan 21, 2026

news preview

Axogen Announces Pricing of Upsized $124 Million Public Offering of Common Stock

ALACHUA, Fla. and TAMPA, Fla.

news source

GlobeNewsWire • Jan 22, 2026

news preview

Axogen, Inc. (AXGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

Axogen, Inc. (AXGN) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

news source

Seeking Alpha • Jan 15, 2026

news preview

¹ Disclosures

Get started with M1

Invest in Axogen Inc.

Open an M1 investment account to buy and sell Axogen Inc. commission-free¹. Build wealth for the long term using automated trading and transfers.

Invest in AXGN on M1